
Layla D. Berry
Examiner (ID: 2498, Phone: (571)272-9572 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1609, 1693, 1623, 1673 |
| Total Applications | 1717 |
| Issued Applications | 1094 |
| Pending Applications | 107 |
| Abandoned Applications | 562 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18837706
[patent_doc_number] => 11845769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Anion exchange stationary phases based on a polyalkylpolyamine polymer layer
[patent_app_type] => utility
[patent_app_number] => 17/176044
[patent_app_country] => US
[patent_app_date] => 2021-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 11725
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 259
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176044
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/176044 | Anion exchange stationary phases based on a polyalkylpolyamine polymer layer | Feb 14, 2021 | Issued |
Array
(
[id] => 16885470
[patent_doc_number] => 20210171665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-10
[patent_title] => POROUS POLYMERIC CELLULOSE PREPARED VIA CELLULOSE CROSSLINKING
[patent_app_type] => utility
[patent_app_number] => 17/248915
[patent_app_country] => US
[patent_app_date] => 2021-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248915
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/248915 | Porous polymeric cellulose prepared via cellulose crosslinking | Feb 11, 2021 | Issued |
Array
(
[id] => 17874321
[patent_doc_number] => 11446313
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof
[patent_app_type] => utility
[patent_app_number] => 17/173340
[patent_app_country] => US
[patent_app_date] => 2021-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 20
[patent_no_of_words] => 27851
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173340
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/173340 | Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof | Feb 10, 2021 | Issued |
Array
(
[id] => 16868464
[patent_doc_number] => 20210161931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => BILE ACID SYNTHESIS PROMOTER, COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS AND FOOD COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 17/171545
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5744
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/171545 | Bile acid synthesis promoter, composition for promoting bile acid synthesis and food composition for promoting bile acid synthesis | Feb 8, 2021 | Issued |
Array
(
[id] => 16839567
[patent_doc_number] => 20210147579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-20
[patent_title] => WATER-SOLUBLE CELLULOSE ETHER AND METHOD FOR PRODUCING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/158714
[patent_app_country] => US
[patent_app_date] => 2021-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158714
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/158714 | WATER-SOLUBLE CELLULOSE ETHER AND METHOD FOR PRODUCING THE SAME | Jan 25, 2021 | Abandoned |
Array
(
[id] => 16807834
[patent_doc_number] => 20210130387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/142936
[patent_app_country] => US
[patent_app_date] => 2021-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17142936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/142936 | PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS | Jan 5, 2021 | Abandoned |
Array
(
[id] => 17399672
[patent_doc_number] => 20220041762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => LOW-MOLECULAR-WEIGHT TREMELLA AURANTIALBA GLUCURONOXYLOMANNAN AS WELL AS PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/429908
[patent_app_country] => US
[patent_app_date] => 2021-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429908
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/429908 | Low-molecular-weight | Jan 5, 2021 | Issued |
Array
(
[id] => 18043647
[patent_doc_number] => 11517580
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-06
[patent_title] => Fucosyltransferase specific inhibition using fucose mimetics
[patent_app_type] => utility
[patent_app_number] => 17/136839
[patent_app_country] => US
[patent_app_date] => 2020-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 15397
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136839
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/136839 | Fucosyltransferase specific inhibition using fucose mimetics | Dec 28, 2020 | Issued |
Array
(
[id] => 16792959
[patent_doc_number] => 20210122776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/135256
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17135256
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/135256 | COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS | Dec 27, 2020 | Abandoned |
Array
(
[id] => 18212803
[patent_doc_number] => 20230059067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => HIGH-SOLUBILITY REBAUDIOSIDE D COMPLEX
[patent_app_type] => utility
[patent_app_number] => 17/788906
[patent_app_country] => US
[patent_app_date] => 2020-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788906
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788906 | HIGH-SOLUBILITY REBAUDIOSIDE D COMPLEX | Dec 24, 2020 | Pending |
Array
(
[id] => 18428699
[patent_doc_number] => 11673909
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/786133
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9096
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786133 | Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof | Dec 17, 2020 | Issued |
Array
(
[id] => 18224544
[patent_doc_number] => 20230063538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => LARGE SCALE PROCESS
[patent_app_type] => utility
[patent_app_number] => 17/785295
[patent_app_country] => US
[patent_app_date] => 2020-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785295
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/785295 | LARGE SCALE PROCESS | Dec 15, 2020 | Pending |
Array
(
[id] => 16932414
[patent_doc_number] => 20210198303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => Steviol Glycoside Compounds, Compositions For Oral Ingestion Or Use, And Method For Enhancing Steviol Glycoside Solubility
[patent_app_type] => utility
[patent_app_number] => 17/120739
[patent_app_country] => US
[patent_app_date] => 2020-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17120739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/120739 | Steviol glycoside compounds, compositions for oral ingestion or use, and method for enhancing steviol glycoside solubility | Dec 13, 2020 | Issued |
Array
(
[id] => 17578754
[patent_doc_number] => 20220135609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => Mannose Derivatives for Treating Bacterial Infections
[patent_app_type] => utility
[patent_app_number] => 17/120441
[patent_app_country] => US
[patent_app_date] => 2020-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17120441
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/120441 | Mannose derivatives for treating bacterial infections | Dec 13, 2020 | Issued |
Array
(
[id] => 19910256
[patent_doc_number] => 12286452
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Amphiphilic aminoglycoside connexin hemichannel inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/119301
[patent_app_country] => US
[patent_app_date] => 2020-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 25
[patent_no_of_words] => 10197
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/119301 | Amphiphilic aminoglycoside connexin hemichannel inhibitors | Dec 10, 2020 | Issued |
Array
(
[id] => 16877987
[patent_doc_number] => 11028120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-08
[patent_title] => CD73 inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/114993
[patent_app_country] => US
[patent_app_date] => 2020-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27691
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17114993
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/114993 | CD73 inhibitors | Dec 7, 2020 | Issued |
Array
(
[id] => 16915799
[patent_doc_number] => 20210188891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => C-TERMINAL HSP90 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/112060
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112060
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112060 | C-terminal Hsp90 inhibitors | Dec 3, 2020 | Issued |
Array
(
[id] => 18329221
[patent_doc_number] => 11634449
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Macrolides and methods of their preparation and use
[patent_app_type] => utility
[patent_app_number] => 17/112743
[patent_app_country] => US
[patent_app_date] => 2020-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 3
[patent_no_of_words] => 94679
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 827
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112743
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/112743 | Macrolides and methods of their preparation and use | Dec 3, 2020 | Issued |
Array
(
[id] => 19479403
[patent_doc_number] => 20240327445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => METHOD FOR PURIFYING SUCRALOSE-6-ACETATE
[patent_app_type] => utility
[patent_app_number] => 18/250957
[patent_app_country] => US
[patent_app_date] => 2020-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250957
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250957 | METHOD FOR PURIFYING SUCRALOSE-6-ACETATE | Nov 26, 2020 | Pending |
Array
(
[id] => 16961479
[patent_doc_number] => 20210212978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => METHOD OF SYNTHESISING SULFORAPHANE
[patent_app_type] => utility
[patent_app_number] => 16/951871
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16951871
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/951871 | Method of synthesising sulforaphane | Nov 17, 2020 | Issued |